Trinity Biotech (TRIBY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY)

TRIB 0.995

-0.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Douglas A. Sevy who wrote (7436)	11/26/1997 12:08:00 PM
From: AgAuUSA	Read Replies (2) of 14328

Ethics panel OKs human testing of AIDS virus Copyright c 1997 Nando.net Copyright c 1997 Agence France-Presse BANGKOK (November 26, 1997 09:47 a.m. EST nando.net) - Thailand's ethics chiefs have approved human trials of a possible AIDS vaccine that targets strains of the HIV virus common in the country, a report said Wednesday. The vaccine, developed from two strains of the human immunodeficiency virus that can cause AIDS, has been approved by the national ethics board but is still subject to the approval of a government scientific committee. If approved, the AIDS Vax vaccine, manufactured by the U.S.-based Vax Gen Inc, would then be tried on 90 intravenous drug users who are not HIV-positive, the Bangkok Post quoted project chief Sricharoen Migasena as saying. The scientist said an earlier test had been conducted on a vaccine using material from only one strain, but the new two-strain variety promised to be more effective.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next